MPM BioImpact LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 13, 2024
Value $
$667M
Signature - Title
Christopher Wolf - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by MPM BioImpact LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MPM BioImpact LLC reported 43 stock holdings with total value $667M as of Q3 2024. Top holdings included CGEM, INSM, OLMA, RNA, and CRNX.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 43 $667M +$122M -$114M +$8.21M CGEM, INSM, OLMA, RNA, CRNX 13F-HR 11/12/2024, 07:40 PM
Q2 2024 44 $644M +$158M -$64.2M +$93.8M CGEM, INSM, OLMA, ITOS, CRNX 13F-HR 8/14/2024, 11:32 AM
Q1 2024 38 $622M +$161M -$77.7M +$83.7M CGEM, GERN, IOVA, ZNTL, ITOS 13F-HR 5/15/2024, 04:22 PM
Q4 2023 32 $427M +$25.4M -$32.5M -$7.07M CGEM, IOVA, OLMA, GERN, ITOS 13F-HR 2/13/2024, 04:06 PM
Q3 2023 32 $375M +$58.6M -$121M -$62.5M CGEM, OLMA, GERN, RPTX, ITOS 13F-HR 11/14/2023, 04:38 PM
Q2 2023 34 $497M +$138M -$67.7M +$70.4M CGEM, ISEE, KDNY, GERN, RETA 13F-HR 8/14/2023, 11:19 AM
Q1 2023 31 $385M +$43.1M -$29.2M +$13.9M CGEM, PRVB, ISEE, ITOS, INBX 13F-HR 5/12/2023, 01:02 PM
Q4 2022 33 $385M +$49.5M -$61M -$11.4M CGEM, ITOS, INBX, RPTX, ISEE 13F-HR 2/14/2023, 12:41 PM
Q3 2022 38 $422M +$74.3M -$14.9M +$59.4M CGEM, ITOS, INBX, VERV, NTLA 13F-HR 11/14/2022, 10:22 AM
Q2 2022 37 $357M +$41.2M -$22.1M +$19.1M CGEM, ITOS, RPTX, MRUS, NTLA 13F-HR 8/11/2022, 05:27 PM
Q1 2022 37 $373M +$23.5M -$38.7M -$15.2M CGEM, ITOS, MRUS, RPTX, HARP 13F-HR 5/13/2022, 12:05 PM
Q4 2021 33 $549M +$39.1M -$58.4M -$19.3M CGEM, ITOS, RPTX, MEIP, MRUS 13F-HR 2/11/2022, 04:37 PM
Q3 2021 33 $645M +$155M -$13.2M +$142M CGEM, ITOS, RPTX, HOWL, TCRR 13F-HR 11/12/2021, 06:19 PM
Q2 2021 14 $609M +$41.6M -$25M +$16.7M CGEM, ITOS, TCRR, RPTX, HARP 13F-HR 8/13/2021, 09:24 AM
Q1 2021 13 $796M +$330M -$33.7M +$296M CGEM, HARP, ITOS, TCRR, RPTX 13F-HR 5/13/2021, 03:46 PM
Q4 2020 13 $569M +$76.8M -$5.68M +$71.2M TCRR, RPTX, ITOS, ONCR, HARP 13F-HR/A 2/24/2021, 04:55 PM
Q4 2020 16 $589M +$90.3M $0 +$90.3M TCRR, RPTX, ITOS, ONCR, HARP 13F-HR 2/16/2021, 06:45 AM
Q3 2020 12 $415M +$64.4M $0 +$64.4M RPTX, TCRR, HARP, ITOS, EPZM Restatement 11/19/2020, 02:36 PM
Q2 2020 11 $376M +$127M -$7.73M +$119M RPTX, HARP, TCRR, EPZM, GTHX 13F-HR 8/12/2020, 12:12 PM
Q1 2020 10 $164M +$13.8M -$46.8M -$33M HARP, EPZM, TCRR, GTHX, TPTX 13F-HR 5/13/2020, 12:16 PM
Q4 2019 12 $282M $0 $0 HARP, EPZM, TCRR, GTHX, ARQL 13F-HR 2/14/2020, 03:03 PM